IMNM
Price
$8.78
Change
+$0.24 (+2.81%)
Updated
Apr 30, 04:59 PM (EDT)
Capitalization
743.08M
8 days until earnings call
IPSC
Price
$0.55
Change
+$0.05 (+10.00%)
Updated
Apr 30, 04:59 PM (EDT)
Capitalization
43.43M
7 days until earnings call
Ad is loading...

IMNM vs IPSC

Header iconIMNM vs IPSC Comparison
Open Charts IMNM vs IPSCBanner chart's image
Immunome
Price$8.78
Change+$0.24 (+2.81%)
Volume$20.07K
Capitalization743.08M
Century Therapeutics
Price$0.55
Change+$0.05 (+10.00%)
Volume$19.03K
Capitalization43.43M
IMNM vs IPSC Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. IPSC commentary
May 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Buy and IPSC is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 01, 2025
Stock price -- (IMNM: $8.54 vs. IPSC: $0.50)
Brand notoriety: IMNM and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 76% vs. IPSC: 158%
Market capitalization -- IMNM: $743.08M vs. IPSC: $43.43M
IMNM [@Biotechnology] is valued at $743.08M. IPSC’s [@Biotechnology] market capitalization is $43.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 6 TA indicator(s) are bullish while IPSC’s TA Score has 5 bullish TA indicator(s).

  • IMNM’s TA Score: 6 bullish, 3 bearish.
  • IPSC’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than IPSC.

Price Growth

IMNM (@Biotechnology) experienced а +4.27% price change this week, while IPSC (@Biotechnology) price change was -6.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.93%. For the same industry, the average monthly price growth was +3.53%, and the average quarterly price growth was -9.41%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 13, 2025.

IPSC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($743M) has a higher market cap than IPSC($43.4M). IMNM YTD gains are higher at: -19.586 vs. IPSC (-50.089). IMNM has higher annual earnings (EBITDA): -109.95M vs. IPSC (-117.21M). IMNM has more cash in the bank: 240M vs. IPSC (198M). IMNM has less debt than IPSC: IMNM (2.72M) vs IPSC (54.6M). IMNM has higher revenues than IPSC: IMNM (10.1M) vs IPSC (2.68M).
IMNMIPSCIMNM / IPSC
Capitalization743M43.4M1,712%
EBITDA-109.95M-117.21M94%
Gain YTD-19.586-50.08939%
P/E RatioN/AN/A-
Revenue10.1M2.68M376%
Total Cash240M198M121%
Total Debt2.72M54.6M5%
TECHNICAL ANALYSIS
Technical Analysis
IMNMIPSC
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 23 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
89%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LCGRX22.030.24
+1.10%
Loomis Sayles Small Cap Growth Retail
JNDVX11.180.05
+0.45%
Janus Henderson U.S. Dividend Income N
VTMFX43.57N/A
N/A
Vanguard Tax-Managed Balanced Adm
AGOCX11.69N/A
N/A
PGIM Jennison Global Equity Income C
DNMDX28.95N/A
N/A
Dunham Monthly Distribution N

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYMR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-0.47%
KYMR - IMNM
56%
Loosely correlated
+0.24%
IDYA - IMNM
55%
Loosely correlated
-0.25%
RXRX - IMNM
53%
Loosely correlated
-2.05%
BEAM - IMNM
53%
Loosely correlated
-0.45%
CCCC - IMNM
51%
Loosely correlated
-2.47%
More